Calcium-Activated Potassium Conductance
- 1 October 1987
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 151 (4) , 455-459
- https://doi.org/10.1192/bjp.151.4.455
Abstract
Neuroleptics are structurally a heterogenous group of compounds which possess antipsychotic activity. They increase dopamine metabolites by blocking dopamine receptors and enhancing presynaptic turnover. This forms the cornerstone of the dopamine hypothesis of neuroleptic action, which is supported by wide-ranging behavioural, physiological and biochemical studies. It is, however, clear that neuroleptics are far less specific for the dopamine receptor than was previously considered. They influence a range of neuronal activities, including calcium-activated potassium conductance, which governs the rate of action potential generation by many neurones. Recent physiological studies indicate that all commonly used neuroleptics alter calcium-activated potassium conductance in central neurones, in concentrations similar to those achieved clinically. An adaptive increase in calcium-activated potassium conductance mechanisms in key sensory processing neurones would render the psychotic patient less susceptible to bombardment by environmental stimuli. This action may explain in part the therapeutic effect of neuroleptics.Keywords
This publication has 32 references indexed in Scilit:
- Neuroleptics decrease calcium-activated potassium conductance in hippocampal pyramidal cellsBrain Research, 1987
- Calmodulin antagonists inhibit aggregation of human, guinea pig and rabbit platelets induced with platelet activating factorFEBS Letters, 1983
- Effects of chronic administration of antipsychotic drugs on GABA and other amino acids in the mesolimbic area of rat brainLife Sciences, 1979
- Influence of neuroleptics on the binding of met-enkephalin, morphine and dihydromorphine to synaptosome-enriched fractions of rat brainNeuropharmacology, 1978
- Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptorsLife Sciences, 1977
- DOPAMINE AND SCHIZOPHRENIAThe Lancet, 1976
- Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidolLife Sciences, 1975
- Drugs, Neurotransmitters, and SchizophreniaScience, 1974
- Reduced range of sensory sensitivity in chronic nonparanoid schizophrenics.Journal of Abnormal Psychology, 1972
- Trial of Maintenance Therapy in SchizophreniaBMJ, 1971